Details for Patent: 8,822,637
✉ Email this page to a colleague
Summary for Patent: 8,822,637
Title: | Somatostatin analogues |
Abstract: | The invention provides cyclo[{4-(NH.sub.2--C.sub.2H.sub.4--NH--CO--O-)Pro}-Phg-DTrp-Lys-Tyr(4-Be- nzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties. |
Inventor(s): | Albert; Rainer (Basel, CH), Bauer; Wilfried (Lampenberg, CH), Bodmer; David (Klingnau, CH), Bruns; Christian (Freiburg, DE), Felner; Ivo (Reinach, CH), Hellstern; Heribert (Heitersheim, DE), Lewis; Ian (Riehen, CH), Meisenbach; Mark (Durmenach, FR), Weckbecker; Gisbert (Biel-Benken, CH), Wietfeld; Bernhard (Efringen-Kirschen, DE) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 13/048,932 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,822,637
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,822,637
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0018891.2 | Aug 1, 2000 |
International Family Members for US Patent 8,822,637
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 034132 | ⤷ Try a Trial | |||
Austria | 393782 | ⤷ Try a Trial | |||
Australia | 2001289778 | ⤷ Try a Trial | |||
Australia | 8977801 | ⤷ Try a Trial | |||
Brazil | 0112859 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |